Centre Hospitalier Universitaire Vaudois
Lausanne, Switzerland
Purpose
to optimize a novel broadly neutralizing antibody against HIV, LN02, and evaluate its potential for future clinical development
Division
Global Health
Date
May 2018
Region Served
GLOBAL
Committed amount
$749,977
Grant topic
HIV
Duration (months)
27
Grantee location
Lausanne, Switzerland
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.